Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
Work
Year: 2011
Type: article
Source: The Lancet Oncology
Authors Luca Gianni, Urania Dafni, Richard D. Gelber, Evandro de Azambuja, Susanne Muehlbauer +20 more
Institutions San Raffaele University of Rome, Frontier Science Foundation-Hellas, Dana-Farber Cancer Institute, Université Libre de Bruxelles, Roche (Switzerland) +25 more
Cites: 25
Cited by: 606
Related to: 10
FWCI: 36.15
Citation percentile (by year/subfield): 100
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green